1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Molnlycke

Anonymous board for Molnlycke


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    7
    Views:
    2,149
  2. anonymous
    Replies:
    18
    Views:
    6,939
  3. anonymous
    Replies:
    1
    Views:
    1,080
  4. anonymous
    Replies:
    4
    Views:
    2,054
  5. Anonymous
    Replies:
    16
    Views:
    8,430
  6. anonymous
    Replies:
    3
    Views:
    3,438
  7. anonymous
    Replies:
    0
    Views:
    1,554
  8. anonymous
    Replies:
    1
    Views:
    2,405
  9. anonymous
    Replies:
    2
    Views:
    2,611
  10. Anonymous
    Replies:
    20
    Views:
    17,075
  11. Anonymous
    Replies:
    6
    Views:
    4,240
  12. Anonymous
    Replies:
    6
    Views:
    4,928
  13. Anonymous
    Replies:
    7
    Views:
    4,576
  14. Anonymous
    Replies:
    2
    Views:
    3,918
  15. Anonymous
    Replies:
    21
    Views:
    13,709
  16. Anonymous
    Replies:
    17
    Views:
    13,516
  17. Anonymous
    Replies:
    2
    Views:
    5,318
  18. Anonymous
    Replies:
    0
    Views:
    2,539
  19. Anonymous
    Replies:
    0
    Views:
    2,862
  20. Anonymous
    Replies:
    0
    Views:
    2,511

Thread Display Options

Loading...